スポンサーリンク
Department of Cardiology, Tokai University School of Medicine | 論文
- Nifekalant Hydrochloride Administration During Cardiopulmonary Resuscitation Improves the Transmural Dispersion of Myocardial Repolarization : Experimental Study in a Canine Model of Cardiopulmonary Arrest
- Transradial Coronary Intervention as the Primary Approach for Acute Myocardial Infarction
- PJ-463 Contrast Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Emergent Percutaneous Coronary Intervention(PJ078,Kidney/Renal Circulation/CKD 4 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circu
- OJ-006 Interrelationships between Residual Plaque Burden of Peri-Stent Margins and Neointimal Reaction within the In-stent Segments following Sirolimus-eluting Stent Implantation(OJ01,Coronary Revascularization, PCI (DES) (IHD),Oral Presentation (Japanese
- PJ-713 Impacts of Vascular Remodeling on Plaque Vulnerability : In Vivo Tissue Characterization using Integrated Backscatter Intravascular Ultrasound(Intravascular endoscopy / Intravascular ultrasound(07)(I),Poster Session(Japanese),The 72nd Annual Scient
- PE-445 The Impact of Contrast Induced Nephropathy on Mortality of Patients with Acute Coronary Syndrome treated with Percutaneous Coronary Intervention(Kidney/Renal circulation(04)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japan
- PE-398 The Final Results of IKAZUCHI-X Registry Study(Coronary revascularization, PCI(14)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-112 Stages of Chronic Kidney Disease Correlate with Major Adverse Cardiac Events and Late Lumen Loss Following the Sirolimus Eluting Stent(Kidney/Renal circulation(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PJ-734 A Protocol for Surgical Treatment in Paitnets with Drug Eluting Stent Implantation(Coronary revascularization, PCI-19, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-381 Does a Low Frequency Ingredient of Late Potential in Brugada Syndrome Reflect Disease Severity?(ECG/Body surface potential mapping/Holter-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- The Irradiation of an Accelerated Heavy ion Beam : Application to the Anti-Arrhythmic Therapy without Massive Myocardial Damage
- Thrombopoietin Contributes to Therapeutic Vasculogenesis through Enhanced Antiapoptotic and Migratory Effects on Endothelial Progenitor Cells(Angiogenesis 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction
- Important Regulatory Role of Activated Platelet-Derived Procoagulant Activity in the Propagation of Thrombi Formed Under Arterial Blood Flow Conditions(Vascular Medicine)
- PE-077 Risk Stratification of Sudden Death in Patients with Chronic Heart Failure by using Consecutive Late Potential by Holter ECG.(ECG/Body surface potential mapping/Holter(03)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanes
- PE-012 Upregulation of Cx43 in Rabbit Hearts by Single Heavy Ion Irradiation Lasts over One Year(Arrhythmia, basic(03)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- What Factor Prescribe the LP Fluctuation in Brugada Syndrome? : Holter ECG Analysis(Clinical Arrhythmias : Pathophysiology and Treatment (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PE-012 Arrhythmogenic Substrates in the Epicardial Borderzone of Rabbit Hearts after Myocardial Infarction : A High-Resolution Optical Mapping Analysis(Arrhythmia, Basic 3 (A) : PE2)(Poster Session (English))
- FRS-147 Circadian Variability of Late Potential Analysis in Brugada Syndrome(Sudden Cardiac Death (A) : FRS18)(Featured Research Session (English))
- Mechanisms of destabilization and early termination of spiral-wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant
スポンサーリンク